ICU Medical Announces Time of Third Quarter 2026 Earnings Conference Call

SAN CLEMENTE, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its third quarter 2026 earnings release and conference call.

GlobeNewsWire • Oct 22, 2026

3 Medical Product Stocks Positioned to Ride on the Industry Tailwinds

Here, we highlight three medical product stocks, ICUI, NEOG and TRLV, which are well positioned to benefit from industry tailwinds and could be worth adding to investors' portfolios.

Zacks Investment Research • Oct 9, 2026

ICU Medical, Inc. (ICUI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

ICU Medical, Inc. (ICUI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Seeking Alpha • Sep 15, 2026

ICU Medical to Participate in Upcoming Investor Conferences

SAN CLEMENTE, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the following investor conferences: Wells Fargo 21st Annual Healthcare Conference on September 9-10, 2026 Company management will attend the Wells Fargo 21st Annual Healthcare Conference, held at the Encore Boston Harbor in Boston, MA, participating in one-on-one meetings on Wednesday, September 9 and Thursday, September 10, 2026.

GlobeNewsWire • Aug 27, 2026

ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings

ICU Medical Inc (NASDAQ:ICUI) on Thursday posted upbeat earnings for the second quarter.

Benzinga • Aug 7, 2026

ICU Medical, Inc. (ICUI) Q2 2026 Earnings Call Transcript

ICU Medical, Inc. (ICUI) Q2 2026 Earnings Call Transcript

Seeking Alpha • Aug 7, 2026

ICU Medical Q2 Earnings Call Highlights

ICU Medical NASDAQ: ICUI reported second-quarter revenue of $548 million, up 6% organically and 1% on a reported basis, as growth in its consumables and infusion systems businesses helped offset continued pressure in Vital Care and the effects of the IV Solutions joint venture deconsolidation.

MarketBeat • Aug 7, 2026

ICU Medical Announces Second Quarter 2026 Results and Updates its Fiscal Year 2026 Guidance

SAN CLEMENTE, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended June 30, 2026.

GlobeNewsWire • Aug 6, 2026

ICU Medical (ICUI) Reports Q2 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for ICU Medical (ICUI) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Investment Research • Aug 7, 2026

ICU Medical (ICUI) Tops Q2 Earnings and Revenue Estimates

ICU Medical (ICUI) came out with quarterly earnings of $2.37 per share, beating the Zacks Consensus Estimate of $1.91 per share. This compares to earnings of $2.1 per share a year ago.

Zacks Investment Research • Aug 7, 2026